kabutan

ONO PHARMA, Last Fiscal Year Net Income Revised Downward by 14%

Mon Apr 28, 2025 4:00 pm JST Revision

4528 ONO PHARMACEUTICAL CO., LTD. 【IFRS】

Guidance Update Report

ONO PHARMACEUTICAL CO., LTD. <4528> [TSE Prime] announced a performance revision after the market closed on April 28th (16:00). The consolidated net income for the fiscal year ending March 2025 has decreased 13.8%, from the previous forecast of 58 billion yen to 50 billion yen (compared to 127 billion yen in the previous period), leading to an increase in the profit decline rate from 54.7% to 60.9%.

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income has decreased 48.9%, from the previous forecast of 16.3 billion yen to 8.35 billion yen (compared to 53.4 billion yen in the same period of the previous year), leading to an increase in the profit decline rate from 69.4% to 84.4%.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 244,661 26,119 26,863 16,359 34.8 40 Oct 31, 2024 IFRS
Oct - Mar, 2024 New 246,661 4,119 5,363 8,359 17.8 40 Apr 28, 2025 IFRS
Revision Rate +0.8% -84.2% -80.0% -48.9% -48.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 485,000 82,000 81,500 58,000 123.5 80 Oct 31, 2024 IFRS
Mar, 2025 New 487,000 60,000 60,000 50,000 106.5 80 Apr 28, 2025 IFRS
Revision Rate +0.4% -26.8% -26.4% -13.8% -13.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 243,959 62,899 64,438 53,486 111.4 40 May 9, 2024 IFRS
Oct - Mar, 2024 Guidance 246,661 4,119 5,363 8,359 17.8 40 Apr 28, 2025 IFRS
YoY +1.1% -93.5% -91.7% -84.4% -84.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 447,187 141,963 143,532 112,723 230.9 70 May 10, 2023 IFRS
Mar, 2024 502,672 159,935 163,734 127,977 266.6 80 May 9, 2024 IFRS
Mar, 2025 Guidance 487,000 60,000 60,000 50,000 106.5 80 Apr 28, 2025 IFRS
YoY -3.1% -62.5% -63.4% -60.9% -60.1%

Related Articles